Tag: grant
-
Small Business Grant Given for Cancer Drug Delivery System
Celsion Corp., a biotechnology drug development company in Columbia, Maryland, has received a Phase 1 Small Business Innovation and Research (SBIR) grant from the National Institutes of Health. This funding will help the company develop its heat-activated liposomal — encapsulated cellular membrane sac — technology in combination with carboplatin, a frequently used oncology drug for…
-
Sensors Developed to Measure Flood Damage to Bridges
Floods have caused more than 60 percent of all bridge failures in the U.S. in the past 30 years, more than all other causes combined. Yet up to now, there have been no systematic ways of measuring the damage caused by floods on the bridge supports at the river bottom. Xiong “Bill” Yu, assistant professor…
-
Foundation Funds R&D for Alzheimer’s Precursor Treatment
The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded a grant of $240,000 to AgeneBio Inc. of Indianapolis, Indiana to develop a new class of small molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease. About 15 percent of aMCI patients progress to Alzheimer’s disease.…
-
Iowa State Awards Research Grants with Economic Potential
Ten individual researchers and teams at Iowa State University in Ames have received grants to develop technologies and processes with potential to grow the state of Iowa’s economy. The state Board of Regents recently approved the grants, totaling more than 942,000, from this year’s Grow Iowa Values Fund. The largest grant, $120,075, was awarded to…
-
Small Business Grant Given for Recurrent Sarcoma Vaccine
MabVax Therapeutics Inc., a biotechnology company in San Diego, California received a Small Business Innovation Research grant from the National Cancer Institute (NCI). The grant will support a Phase II clinical trial with 134 metastatic sarcoma — cancer of connective or supportive tissue — patients in a randomized, multicenter, double-blind study of a vaccine developed…
-
Grant Awarded for Nicotine Vaccine
Selecta Biosciences Inc. in Watertown, Massachusetts received a grant for $3 million from the National Institute on Drug Abuse, a part of National Institutes of Health (NIH), to advance development of an enhanced vaccine to help treat nicotine addiction and aid in smoking cessation and relapse prevention. The grant will fund a candidate from Selecta’s…
-
Georgia Tech to Offer Stem Cell Bio-manufacturing Program
Georgia Institute of Technology in Atlanta has received a $3 million grant from National Science Foundation (NSF) to develop engineering methods for stem cell production, in order to meet the anticipated demand for stem cells. Stem cell research is destined to have a major impact on medical science in fields such as regenerative medicine, drug…
-
Texas City, University Get Grant for Sci/Tech Incubator
A partnership between Texas State University-San Marcos and the city of San Marcos has landed a $1.85 million award from the U.S. Economic Development Administration to build a new Science, Technology, and Advanced Research (STAR) building. The university says the new building will be used as a location for start-up and early-stage businesses, and provide…
-
Sanofi-aventis, Scripps to Partner on Personalized Medicines
Sanofi-aventis (U.S.) in Bridgewater, New Jersey and Scripps Genomic Medicine in San Diego, California announced today an alliance to advance research initiatives in individualized medicine. Sanofi-aventis is a French pharmaceutical company, but with a U.S. subsidiary. Scripps Genomic Medicine is a division of Scripps Health, a private not-for-profit community health system in San Diego. In…
-
Biotech Company Awarded Grant for Melanoma Immunotherapy
Lentigen Corporation, a biotechnology company in Gaithersburg, Maryland has received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant to advance an immunotherapy for melanoma invented by Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina. In this program, Lentigen will collaborate with Nishimura. Melanoma is the most dangerous…